Successes and challenges of HIV treatment programs in Haiti: Aftermath of the earthquake

HIV Therapy

Volumn 4, Issue 2, 2010, Pages 145-160

  Koenig, Serena ^a   Ivers, L C ^a   Pace, S ^c   Destine, R ^c   Leandre, F ^b   Grandpierre, R ^c   Mukherjee, J ^a   Farmer, P E ^a   Pape, J W ^c,d  

^a BRIGHAM AND WOMEN S HOSPITAL   (United States)

^b PARTNERS IN HEALTH   (United States)

^c Department of Adolescent Medicine   (United States)

^d WEILL CORNELL MEDICAL COLLEGE   (United States)

Author keywords

Adherence; Antiretroviral therapy; Haiti; HIV AIDS; Quality of care; Tuberculosis

Indexed keywords

HUMAN IMMUNODEFICIENCY VIRUS ANTIBODY;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ADULT; CONTROLLED STUDY; EARTHQUAKE; FEMALE; GOVERNMENT; HAITI; HEALTH CARE ORGANIZATION; HEALTH CARE QUALITY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; HUMAN IMMUNODEFICIENCY VIRUS PREVALENCE; KAPOSI SARCOMA; LONG TERM CARE; MAJOR CLINICAL STUDY; MALE; MORTALITY; PRACTICE GUIDELINE; PREVALENCE; REVIEW; RISK FACTOR; RURAL HEALTH CARE; TREATMENT OUTCOME; TUBERCULOSIS; VERTICAL TRANSMISSION; VIROTHERAPY;

EID: 77951683054     PISSN: 17584310     EISSN: None     Source Type: Journal    
DOI: 10.2217/hiv.10.6     Document Type: Review

References (54)

1. CDC: Kaposi's sarcoma and Pneumocystis pneumonia. MMWR Morb. Mortal. Wkly Rep. 30 (25), 409-410 (1981).
2. Hymes KB, Cheung T, Greene JB et al.: Kaposi's sarcoma in homosexual men - a report of eight cases. Lancet 2 (8247), 598-600 (1981).
3. CDC: Opportunistic infections and Kaposi's Sarcoma among Haitians in the United States. MMWR Morb. Mortal. Wkly Rep. 31 (26), 353-354, 360-361 (1982).
4. Liautaud B, Laroche C, Duvivier J, Pean-Guichard C: Kaposi's sarcoma in Haiti: unknown reservoir or recent appearance? Ann. Dermatol. Venereol. 110 (3), 213-219 (1983).
5. Moskowitz LB, Kory P, Chan JC, Haverkos HW, Conley FK, Hensley GT: Unusual causes of death in Haitians residing in Miami: high prevalence of opportunistic infections. JAMA 250 (9), 1187-1191 (1983).
6. Jaffe HW, Bregman DJ, Selik RM: Acquired immune deficiency syndrome in the United States: the first 1, 000 cases. J. Infect. Dis. 148 (2), 339-345 (1983).
7. Pitchenik AE, Fischl MA, Dickinson GM et al.: Opportunistic infections and Kaposi's sarcoma among Haitians: evidence of a new acquired immunodeficiency state. Ann. Intern. Med. 98 (3), 277-284 (1983).
8. Farmer PE: AIDS and Accusations. University of California Press, Berkely, CA, USA (1996).
9. Pape JW, Liautaud B, Thomas F et al.: Characteristics of the acquired immunodeficiency syndrome (AIDS) in Haiti. N. Engl. J. Med. 309 (16), 945-950 (1983).
10. Pape JW, Johnson WD: Epidemiology of AIDS in the Caribbean. In: Bailleire's Clinical Tropical Medicine and Communicable Diseases, AIDS and HIV Infection in the Tropics. Harcourt Brace, London, UK (1988).
11. Cayemittes M, Placide MF, Mariko S et al.: Enquete mortalité, morbidité et utilisation des services EMMUS-e Haïti 2005-2006. Pétionville and Calverton, Insthut Haïtien de l'Enfance, ORC Macro (2006).
12. Pape JW, Deschamps MM, Verdier RI et al.: The urge for an AIDS vaccine: perspectives from a developing country. AIDS Res. Hum. Retroviruses 8 (8), 1535-1537 (1992).
13. Pape JW, Johnson WD, Stanback ME et al.: Prevalence of HIV infection and high-risk activities in Haiti. J. Acquir. Immune Defic. Syndr. 3, 995-1001 (1995).
14. Boulos R, Halsey NA, Holt E et al.: HIV-1 in Haitian women 1982-1988. The Cite Soleil/JHU AIDS Project Team. J. Acquir. Immune Defic. Syndr. 3 (7), 721-728 (1990).
15. Stamm WE, Handsfield HH, Rompalo AM, Ashley RL, Roberts PL, Corey L: The association between genital ulcer disease and acquisition of HIV infection in homosexual men. JAMA, 260 (10), 1429-1433 (1988).
16. Keet IP, Lee FK, Van Griensven GJ, Lange JM, Nahmias A, Coutinho RA: Herpes simplex virus type 2 and other genital ulcerative infections as a risk factor for HIV-1 acquisition. Genitourin. Med. 66 (5), 330-333 (1990).
17. Walton DA, Farmer PE, Lambert W, Leandre F, Koenig SP, Mukherjee JS: Integrated HIV prevention and care strengthens primary health care: lessons from rural Haiti. J. Public Health Policy 25 (2), 137-158 (2004).
18. Connor EM, Sperling RS, Gelber R et al.: Reduction of maternal-infant transmission of human immunodeficiency virus type 1 with zidovudine treatment. Pediatric AIDS Clinical Trails Group Protocol 076 Study Group. N. Engl. J. Med. 331 (18), 1173-1180 (1994).
19. Farmer PE, Leandre F, Mukherjee JS et al.: Community-based approaches to HIV treatment in resource-poor settings. Lancet 358 (9279), 404-409 (2001).
20. Koenig SP, Leandre F, Farmer PE: Scaling-up HIV treatment programmes in resource-limited settings: the rural Haiti experience. AIDS 18 (Suppl. 3), S21-S25 (2004).
21. Farmer PE, Leandre F, Mukherjee JS, Gupta R, Tarter L, Kim JY: Community-based treatment of advanced HIV disease: introducing DOT-HAART (directly observed therapy with highly active antiretroviral therapy). Bull. World Health Organ. 79 (12), 1145-1151 (2001).
22. th IAS Conference on HIV Pathogenesis, Treatment and Prevention. Cape Town, South Africa, 10-22 July 2009.
23. Ivers LC, Van Wassenhove J, Jerome G, Lambert W, Mukherjee JS: Global health initiatives in Haiti and Rwanda - facility-level ana lysis of impact on health systems, preliminary report. Partners In Health, Boston, MA, USA (2009).
24. Mukherjee JS, Ivers L, Leandre F, Farmer PE, Behforouz H: Antiretroviral therapy in resource-poor settings: decreasing barriers to access and promoting adherence. J. Acquir. Immune Defc. Syndr. 43 (Suppl. 1), S123-S126 (2006).
25. Mukherjee JS, Leandre F, Lambert W et al.: Excellent outcomes, high retention in treatment, and low rate of switch to second line ART in community based HIV treatment program in Haiti. Presented at: XVII International AIDS Conference. Mexico City, Mexico, 3-8 August 2008.
26. Peck R, Fitzgerald DW, Liautaud B et al.: The feasibility, demand, and effect of integrating primary care services with HIV voluntary counseling and testing: evaluation of a 15-year experience in Haiti, 1985-2000. J. Acquir. Immune Defc. Syndr. 33 (4), 470-475 (2003).
27. Deschamps MM, Fitzgerald DW, Pape JW, Johnson WD Jr: HIV infection in Haiti: natural history and disease progression. AIDS 14 (16), 2515-2521 (2000).
28. Fitzgerald DW, Severe P, Joseph P et al.: No effect of isoniazid prophylaxis for purified protein derivative-negative HIV-infected adults living in a country with endemic tuberculosis: results of a randomized trial. J. Acquir. Immune Defic. Syndr. 28 (3), 305-307 (2001).
29. Verdier RI, Fitzgerald DW, Johnson WD Jr, Pape JW: Trimethoprim- sulfamethoxazole compared with ciprofloxacin for treatment and prophylaxis of Isospora belli and Cyclospora cayetanensis infection in HIV-infected patients. A randomized, controlled trial. Ann. Intern. Med. 132 (11), 885-888 (2000).
30. DeHovitz JA, Pape JW, Boncy M, Johnson WD Jr: Clinical manifestations and therapy of Isospora belli infection in patients with the acquired immunodeficiency syndrome. N. Engl. J. Med. 315 (2), 87-90 (1986).
31. Pape JW, Jean SS, Ho JL, Hafner A, Johnson WD Jr: Effect of isoniazid prophylaxis on incidence of active tuberculosis and progression of HIV infection. Lancet 342 (8866), 268-272 (1993).
32. Severe P, Leger P, Charles M et al.: Antiretroviral therapy in a thousand patients with AIDS in Haiti. N. Engl. J. Med. 353 (22), 2325-2334 (2005).
33. WHO: Antiretroviral therapy for HIV infection in adults and adolescents in resource-limited settings: toward universal access. Recommendations for a public health approach. WHO (2006).
34. Leger P, Charles M, Severe P, Riviere C, Pape JW, Fitzgerald DW: 5-year survival of patients with AIDS receiving antiretroviral therapy in Haiti. N. Engl. J. Med. 361 (8), 828-829 (2009).
35. Joseph P, Severe P, Ferdinand S et al.: Multidrug-resistant tuberculosis at an HIV testing center in Haiti. AIDS 20 (3), 415-418 (2006).
36. George E, Noel F, Bois G et al.: Antiretroviral therapy for HIV-1 infected children in Haiti. J. Infect. Dis. 195 (10), 1411-1418 (2007).
37. Dorjgochoo T, Noel F, Deschamps MM et al.: Risk factors for HIV infection among Haitian adolescents and young adults seeking counseling and testing in Port-au-Prince. J. Acquir. Immune Defic. Syndr. 52 (4), 498-508 (2009).
38. Charles M, Noel F, Leger P, Severe P et al.: Survival, plasma HIV-1 RNA concentrations and drug resistance in HIV-1-infected Haitian adolescents and young adults on antiretrovirals. Bull. World Health Organ. 86 (12), 970-977 (2008).
39. Calmy A, Pinoges L, Szumilin E et al.: Generic fixed-dose combination antiretroviral treatment in resource-poor settings: multicentric observational cohort. AIDS 20 (8), 1163-1169 (2006).
40. Ferradini L, Jeannin A, Pinoges L et al.: Scaling up of highly active antiretroviral therapy in a rural district of Malawi: an effectiveness assessment. Lancet 367 (9519), 1335-1342 (2006).
41. Stringer JS, Zulu I, Levy J, Stringer EM, Mwango A, Chi BH: Rapid scale-up of antiretroviral therapy at primary care sites in Zambia: feasibility and early outcomes. JAMA 296 (7), 782-793 (2006).
42. Braitstein P, Brinkhof MW, Dabis F et al.: Mortality of HIV-1-infected patients in the first year of antiretroviral therapy: comparison between low-income and high-income countries. Lancet 367 (9513), 817-824 (2006).
43. Rebick G, Charles M, Leger P et al.: Antiretroviral therapy in adults and adolescents with AIDS in Haiti from 2003-2007: a cohort ana lysis. Presented at: XVII International AIDS Conference. Mexico City, Mexico, 3-8 August 2008.
44. Koenig SP, Riviere C, Leger P et al.: High mortality among patients with AIDS who received a diagnosis of tuberculosis in the first 3 months of antiretroviral therapy. Clin. Infect. Dis. 48 (6), 829-831 (2009).
45. Mofenson LM: Advances in the prevention of vertical transmission of human immunodeficiency virus. Semin. Pediatr. Infect. Dis. 14 (4), 295-308 (2003).
46. Jean SS, Verdier RI, Pape JW, Reed GW, Johnson WD Jr, Wright P: The natural history of human immunodefciency virus 1 infection in Haitian infants. Pediatr. Infect. Dis. J. 18 (1), 58-63 (1999).
47. Behforouz HL, Farmer PE, Mukherjee JS: From directly observed therapy to accompagnateurs: enhancing AIDS treatment outcomes in Haiti and Boston. Clin. Infect. Dis. 38 (Suppl. 5), S429-S436 (2004).
48. Noel F, Mehta S, Zhu Y et al.: Improving outcomes in infants of HIV-infected women in a developing country setting. PLoS One 3 (11), e3723 (2008).
49. Deschamps MM, Noel F, Bonhomme J et al.: Prevention of mother-to-child transmission of HIV in Haiti. Rev. Panam. Salud Publica 25 (1), 24-30 (2009).
50. Ivers L, Smith-Fawzi MC, Leandre F et al.: Very low rate of transmission of HIV infection from mother-to-child in rural Haiti: the Zanmi Lasante experience. Presented at: XVII International AIDS Conference. Mexico City, Mexico, 3-8 August 2008.
51. Mitnick C, Bayona J, Palacios E et al.: Community-based therapy for multidrug-resistant tuberculosis in Lima, Peru. N. Engl. J. Med. 348 (2), 119-128 (2003).
52. GHESKIO report to PEPFAR, 2006.
53. Dugan IJ: Haitian AIDS clinic regroups. Wall Street Journal, 27 January (2010).
54. Cohen J: Haiti making headway under hellacious circumstances. Science 313 (5786), 470-473 (2008).